In the treatment of Diabetes Mellitus (DM), which develops on the basis of insulin resistance in patients with lipodystrophy (LD) often require high doses of insulin. Traditionally in practice is to gradually increase the insulin doses to achieve blood glucose normalization. The fact that high insulin doses require a larger injection volume, which causes impairment in the absorption of insulin from the subcutaneous tissue to the circulation. In this article, we discussed the clinical approach to insulin practice in the treatment of DM in patients with LD and reviewed systematically the literature
As known insulin therapy is associated with induration of subcutaneous fat at injections sites calle...
NIDDM is the result of concomitant defects in both insulin secretion and insulin action. Although pl...
Diabetes mellitus: is a chronic endocrine disorder accompanied by elevated blood glucose levels due ...
peer reviewedManagement of diabetes mellitus can be responsible for cutaneous adverse events. For ex...
Diabetes mellitus is a collection of metabolic illnesses marked by chronic hyperglycemia caused by i...
Background. Lipodystrophy is one of the clinical complications of insulin injection that affects ins...
Diabetes Mellitus (DM) is the most common cause of renal failure and ESRD all over the world, and of...
Lipohypertrophy (LD) is one of the most common complications of subcutaneous insulin injection. Many...
DM is metabolic disorder characterized with hyperglycaemia at absolute shortage of endogenous insuli...
B efore the development of purifiedinsulin in the 1970s, lipoatrophywas a common complication of in-...
Patients with type 2 diabetes mellitus (T2DM) often feature resistance to endogenous and exogenous i...
L ipohypertrophy is a common side ef-fect of subcutaneous insulin therapy,occurring in up to 50 % of...
Lipohypertrophy has been a recognized complication of insulin therapy. Despite improvements in insul...
Summary: Lipoatrophy and lipohypertrophy were the most frequently reported local complications of co...
Diabetes mellitus is a heterogeneous group of disorders characterized by hyperglycaemia due to an ab...
As known insulin therapy is associated with induration of subcutaneous fat at injections sites calle...
NIDDM is the result of concomitant defects in both insulin secretion and insulin action. Although pl...
Diabetes mellitus: is a chronic endocrine disorder accompanied by elevated blood glucose levels due ...
peer reviewedManagement of diabetes mellitus can be responsible for cutaneous adverse events. For ex...
Diabetes mellitus is a collection of metabolic illnesses marked by chronic hyperglycemia caused by i...
Background. Lipodystrophy is one of the clinical complications of insulin injection that affects ins...
Diabetes Mellitus (DM) is the most common cause of renal failure and ESRD all over the world, and of...
Lipohypertrophy (LD) is one of the most common complications of subcutaneous insulin injection. Many...
DM is metabolic disorder characterized with hyperglycaemia at absolute shortage of endogenous insuli...
B efore the development of purifiedinsulin in the 1970s, lipoatrophywas a common complication of in-...
Patients with type 2 diabetes mellitus (T2DM) often feature resistance to endogenous and exogenous i...
L ipohypertrophy is a common side ef-fect of subcutaneous insulin therapy,occurring in up to 50 % of...
Lipohypertrophy has been a recognized complication of insulin therapy. Despite improvements in insul...
Summary: Lipoatrophy and lipohypertrophy were the most frequently reported local complications of co...
Diabetes mellitus is a heterogeneous group of disorders characterized by hyperglycaemia due to an ab...
As known insulin therapy is associated with induration of subcutaneous fat at injections sites calle...
NIDDM is the result of concomitant defects in both insulin secretion and insulin action. Although pl...
Diabetes mellitus: is a chronic endocrine disorder accompanied by elevated blood glucose levels due ...